Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cardiovascular > CV Drugs > Flashcards

CV Drugs Flashcards

1
Q

Name some ACE inhibitors

A

Ramipril, Enalipril, Lisinopril, Perindopril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACE Inhibitor side effects and contra indications

A

SIDE EFFECTS OF ACE INHIBITORS
• Dizziness
• Orthostatic hypotension
• GI distress
• Cough
• Acute kidney injury

Contra-indicated
• Bilateral or renal artery stenosis
• Hyperkalaemia
• Hypotension

Rarely
• Angioedema
• Swelling of mouth , lips and throat
• Black people and smokers most at
risk
• May be severe and life-threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Action of an ACE inhibitor:

A

Inhibits angiotensin l being converted to angiotensin ll
No angiotensin ll means:
No aldosterone release ~ reduces Na~ reduces fluid
Limited vasoconstriction so blood vessels dilate
No release of ADH (less fluid and less vasoconstriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What should be used if ACE inhibitor can’t be tolerated eg if causes persistent dry cough

A

ARB
Angiotensin receptor blocker
Do not inhibit the breakdown of bradykinin so no persistent dry cough

Drugs: candesartan, irbesartan, losartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some ARB’s

A

Candesartan, Irbesartan, Losartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name some calcium channel blockers

A

Two types
Dihydropyridines (nifedipine, amlodipine, felodipine) - predominantly
affecting vascular smooth muscle causing vasodilation
Non- dihydropyridines (verapamil & diltiazem) – SLOW THE HEART RATE affecting myocardial tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Calcium channel side effects

A

Flushing
Headache
Ankle swelling
Dizziness
• Tend to disappear within a few days
Constipation
Bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Action of calcium channel blockers

A

Inhibit calcium channels on smooth muscle cells of arteries
Reduced Ca influx, reduced contraction strength,
Reduced rate and force of contraction
Peripheral vasodilation
Coronary vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name some thiazide type diuretics

A

Bendroflumethiazide, indapamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Action of diuretics

A

Cause urine loss from the kidneys, by inhibiting sodium and water re absorption
Decrease blood volume, cardiac output, total peripheral resistance
Not first line treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side effects of thiazide type diuretics

A

Common
Dizziness
Electrolyte imbalance
Gastrointestinal disturbances

Rare
Blood disorders
Bone marrow suppression
Impotence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name some beta blockers

A

Atenolol, carvedilol, metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Action of beta blockers

A

• Blocks to B1 adrenergic receptors of the heart and the kidneys therefore causing reduction in calcium uptake, reducing force and velocity of contractions
• Vasodilating affects
Reduction in sympathetic drive, therefore heart rate decreases overall reducing cardiac output and BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of beta blockers

A

Side Effects: Bronchospasms in susceptible individuals (due to having beta || receptors on the lungs) so avoid in asthma patients, fatigue, cold extremities, Nightmares, affect carbohydrate metabolism and increase risk of T2 diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Case Study:
49 year old cashier
Caucasian
Type 2 diabetes for last 12 years
BP 150/95 at routine diabetic check
Similar readings in notes going back over four months
BMI 35
Smoked since teenage years
What should you do?

A

ACE inhibitor or ARB (check renal function first)
Then add CCB or thiazide type diuretics
Then all 3
Step 4- consider seeking expert advice or low dose spironolactone if blood potassium is < or equal to 4.5 mmol/l, alpha blocker or beta blocker if blood potassium is > 4.5 mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name some nitrates

A

GTN spray- under tongue
GTN IV nitrates- severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Action and when to use of nitrates:

A

Vasodilators increasing coronary blood flow
Decrease after and pre load
Decrease myocardial workload, decreased oxygen demand

Use: prophylaxis of angina/ acute heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Side effects and contraindications of nitrates:

A

Headache- make sure to warn people and that’s when you know its working (treat with paracetamol)
Hypotension - dizzy so take sat down
Syncope
Facial flushing

Contraindications:
Acute circulatory failure, shock, head trauma, severe hypotension, aortic stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the use for beta blockers:

A

Hypertension, angina, myocardial infarction, arrhythmias, heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the use for calcium channel blockers:

A

Prophylaxis of angina, hypertension, arrhythmias, use when beta blockers aren’t appropriate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Name some antiplatelets

A

Aspirin, Ticagrelor, Clopidogrel, Plasugrel
Can use them together as they block different pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the action of antiplatelets

A

Disrupt platelet activation via a number of mechanisms including inhibition of platelet agonists, adhesion or aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the use of antiplatelets?

A

Revascularisation to restore sufficient blood flow to affected vessel (repercussion).
Inhibit clot formation and support plaque stabilisation
Secondary prevention of CV disease, TIA, stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Side Effects and contraindications of anti platelets:

A

Bronchospasms, GI bleeds, GI irritation, tinnitus

Contraindications:
Bleeding risk, low platelet count, allery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What dose should aspirin, ticagrelor and prasugrel be given?

A

Aspirin:
Loading at 300mg, then carry on at 75mg

Ticagrelor:
Loading at 180mg, 90mg BD

Prasugrel:
60mg stat then 10 or 5 mg daily (PCI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Name some glycoprotein ||b / |||a antagonists.

A

ABICIXIMAB,EPTIFIBRATIDE, TIOFIBRAN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe the action and use of glyco proteins:

A

Action:
Inhibit the final common pathway involved in platelet aggregation

Use:
prevention of ischaemic cardiac complications in patients undergoing PCI
Short term prevention of MI in patients with unstable angina not responding to conventional treatment & who are scheduled for a PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Side effects and contra indications of glycoproteins:

A

Bleeding, back pain, fever, headaches, hypotension, nausea

Active internal bleeding, hypertensive retinopathy, majorly surgery within last 2 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Name some anticoagulants and what is it used for?

A

Heparin- Enoxaparin, deltaoarin, tinzaparin

Fondaparinux- subcutaneous injection

Uses: thromboprophylaxis, unstable angina, STEMI, NSTEMI, DVT, PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe the action of anticoagulants.

A

Prevents blood from clotting by suppressing the synthesis or function of various clotting factors
Anti- thrombotic
Doesn’t thin the blood, it just makes it less likely to clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Side effects and contra indication of anticoagulants:

A

Side effects- bleeding, hyperkalaemia, HIT

Contra indication- after major trauma, peptic ulcer, severe hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Use of ACE Inhibitors/ ARB’s

A

Heart failure, hypertension, prophylaxis post MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Describe the use and action of nicorandil

A

Prevention and long term management of angina
Potassium channel activator with nitrate component too
Arterial and venous vasodilating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Side effects and contraindications of nicrorandil (angina)

A

Headaches, Ulceration, Dizziness, Flushing

Severe hypotension, LV Failure, hypovolaemia, acute pulmonary oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Use and Action of ranolazine

A

Use s an adjunct in stable angina
Facilitates myocardial relaxation (decreases calcium)- does not affect heart rate or BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Side effects and contra indications of ranolazine (angina)

A

Dizziness, headache, constipation, nausea, vomiting

CI - Severe renal impairment, Caution long QT syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Use and action of ivabradine

A

Use- treatment of angina in patients with normal sinus rhythm
Action- lowers heart rate by acting on sinus node
- decreases myocardial oxygen demands
- no effect on BP or contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Side effects and contra indications of ivabradine (angina)

A

GI, nausea, constipation, diarrhoea

CI heat rate <75
Acute MI, unstable angina, unstable heart failure

(MANY DRUG INTERACTIONS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Describe the use and action of statins:

A

Primary or secondary prevention of CV events, hyperlipidaemia

Action- HMG - CoA reductive inhibitors
Block the enzyme involved in cholesterol synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Common side effects and contra indications of statins:

A

Muscle aches and pains
Myopathy - Rhabdomyolysis
Nausea, insomnia

CI - liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Name some thrombolytics and describe when they should be used.

A

Streptokinase, Tenectoplase, Alteplase

Use between 6-12 hours of symptoms, ideally within 90mins in primary PCI unavailable
Use for: acute myocardial infarction, PE, ischaemic stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

How do thrombolytics work and what are some side effects?

A

Fibrinolytic drug activate plasminogen which turns to plasmin which then degrades the fibrin in th clot, breaking up the thrombus

Side effects: risk of cerebral bleed
(MANY ABSOLUTE/RELATIVE CONTRAINDICATIONS) - must decide what is more beneficial towards the patient

43
Q

Describe the secondary prevention management treatment following an MI

A

Aspirin - 75 mg once daily
Another antiplatelets eg clopidogrel or ticagrelor (low risk of bleeding) for up to 12 months
Atorvastatin - 80mg once daily
ACE Inhibitors (eg ramipril titrated as tolerated to 10mg once daily)
Atenolol or other beta blocker (bisnoprolol) titrated as high as tolerated
Aldosterone antagonist for those with clinical heart failure (ie eplerenone titrated to 50mg once daily)

44
Q

NICE guidelines for stable angina.

A

Either a beta blocker or a calcium channel blocker first line
If the symptoms are not adequately controlled (or cannot tolerate) consider switching to an alternative or use a combination of the first two

If the patients symptoms are not adequately controlled by one or a combination then consider a third line – long acting nitrate, ivabradine or ranolazine

If in combination with a beta blocker – not verapamil or diltiazem

Only if patient cannot tolerate calcium channel blockers or beta blockers should monotherapy with nitrate, ivabradine or ranolazine be offered.

Triple therapy should be considered whilst awaiting revascularisation

45
Q

Management of NSTEMI/ Unstable angina

A

Sub lingual GTN or IV nitrates § Morphine
Oral Beta Blockers
Aspirin
Ticagrelor / Clopidogrel § ACE inhibitor
Statin
Fondaparinux

46
Q

Acute NSTEMI treatment (BATMANO):

A

B- Beta blockers unless contraindicated
A – Aspirin 300mg stat dose
T – Ticagrelor 180mg stat dose (clopidogrel 300mg is an alternative)
M – Morphine titrated to control pain
A – Anticoagulant: Low Molecular Weight Heparin (LMWH) at treatment dose (e.g. enoxaparin 1mg/kg twice daily for 2-8 days)
N – Nitrates (e.g. GTN) to relieve coronary artery spasm
O - oxygen only if their oxygen saturations are dropping (i.e. <95%).

47
Q

Initial treatment for an MI:

A

§ Pain relief & antiplatelets
§ Diamorphine / Morphine
§ Oxygen
§ Sublingual GTNitrate or IV
§ Aspirin
§ Cyclizine or metoclopramide

§ Thrombolysis with or without heparin

§ IV beta blockers, IV nitrates (if suitable)

§ Aspirin , ACE inhibitors , oral beta blockers . Lipid lowering agents, dual antiplatelets

§ Angiography as needed , revascularisation as needed

48
Q

Which of the following drugs must not be given with verapamil:
Bisoprolol,
Telimisartan,
Ticagrelor,
Aspirin

A

Bisoprolol

49
Q

Nam the three types of diuretics for HF symptom relief:

A

Loop (target the loop of Henley)
Thiazide (target the distal convoluted tube)
Aldosterone antagonist

50
Q

Nam some loop diuretics to treat HF symptoms:

A

Furosemide , Bumetanide , Torasemide

51
Q

How do loop diuretics work in the symptom relief of HF?

A

Inhibit reabsorption from the ascending limb of the loop of Henlé in the renal tubule
• Inhibit the sodium-potassium-chloride cotransporter in the thick ascending limb
• This transporter normally reabsorbs about 25% of the sodium load
• leads to both diuresis (increased water loss) and natriuresis (increased sodium loss).
• They
– Reduce preload, thus reducing ventricular filling
– Improve pulmonary vascular congestion by decreasing filling pressures.

52
Q

What tests Ned to be performed before starting HF patient on loop diuretics?

A

Measure of:
Renal Function
Serum Electrolytes
Blood pressure

Make sure to start on a low dose
Recheck measurements 1-2 weeks after starting treatment and each time dose increases.

• Earlier monitoring (after 5-7 days) may be required for people:
• With existing chronic kidney disease stage 3 or higher.
• Aged 60 years or over.
• With relevant comorbidities such as diabetes mellitus or peripheral arterial disease.
• Taking a combination of a diuretic plus an angiotensin-converting enzyme (ACE) inhibitor, an angiotensin-II receptor antagonist (AIIRA), or an aldosterone antagonist.

53
Q

Time of the day and dose of loop diuretics for HF

A

Titrate the dose of loop diuretic up or down according to symptoms and signs of fluid overload; use the lowest possible dose to control symptoms.
● once a day, in the morning, but it can be given twice a day (morning and lunchtime) for additional diuresis.
● Adjust the timing of doses to suit their social needs.
● With heart failure and preserved ejection fraction the maximum initial dose is up to 80 mg
furosemide.

● SICK DAY RULES :
If they develop diarrhoea and vomiting while taking, a diuretic, they should
● maintain their fluid intake and stop the diuretic for 1-2 days until they recover.
● If symptoms persist beyond 2 days they should see a GP and have their bloods checked..

54
Q

Who should you not prescribe loop diuretics to?

A

Do not prescribe loop diuretics to people with:
– Hypovolaemia and dehydration (with or without accompanying hypotension).
– Severe hypokalaemia or severe hyponatraemia.
– Anuria, acute kidney injury or chronic kidney disease due to nephrotoxic or hepatotoxic drugs, or associated with hepatic coma.
– Chronic kidney disease (CKD) with a creatinine clearance below 30 mL/min/1.73m2. – Addison’s disease.
– Liver cirrhosis associated with comatose and pre-comatose state.
– Porphyria.
– Cardiac arrhythmias (contraindication for torasemide).

55
Q

Adverse effects of loop diuretics:

A

Adverse effects of loop diuretics include:
– Water and electrolyte imbalance : Na , Chloride, K , Mg, Ca
•Hyponatraemia e.g. confusion, muscle cramps, muscle weakness, dizziness, drowsiness, and vomiting
•Hypochloraemia,
•Hypokalaemia, - neuromuscular symptoms (muscular weakness and paralysis), intestinal symptoms (including vomiting and constipation), renal symptoms (polyuria), and cardiac symptoms (including palpitations).
•Hypomagnesaemia
•Hypocalcaemia
Hypotension

56
Q

Name some thiazide diuretics:

A

Bendroflumethiazide, indapamide, metolazone, chlorthalidone

57
Q

Thiazide diuretic in HF symptom relief:

A

Bendroflumethiazide, indapamide, metolazone, chlorthalidone
• Inhibit the sodium-chloride transporter in the distal tubule.
• Less efficacious than loop diuretics in producing diuresis and natriuresis.
• Can be added in addition to Loop diuretic to potentiate their action
• Maximum diuresis at low doses
• Act within 1-2 hours and last 6-24 hours
• Oral only

58
Q

Name some aldosterone antagonists:

A

spironolactone, eplerenone

59
Q

How does aldosterone antagonist work?

A

Block the activity of aldosterone, an adrenal cortex hormone that causes sodium retention.
• Useful in heart failure following an MI
• Recommended in moderate-to-severe heart failure
• Aldosterone antagonists (spironolactone and eplerenone) are recommended in patients with – NYHA class II to IV heart failure
– LVEF of 35% or less, unless contraindicated
• Decrease the morbidity and mortality associated with symptomatic chronic heart failure
• Spironolactone and eplerenone can both cause hyperkalaemia

If experiencing gynacasmastia swap to eplerenone

60
Q

ACEInhibitors for AF

A

• Reduce the load on the heart pre & post load
• Decrease symptoms, slow disease progression & prolong life in heart failure
• Most appropriate vasodilators as they lower both the arterial & venous resistance by preventing the increase in angiotensin 2 often present in heart failure.
• Cardiac output increase because the renovascular resistance falls there in an increase in renal blood flow.
• Can use ARB ( ACE II) if ACE not tolerated • E.g. ramipril, lisinopril, candesartan, losartan

61
Q

How do you monitor ACE Inhibitors / ARB in a HF patient?

A

• Measure renal function, serum electrolytes, and blood pressure before prescribing – Recheck 1-2 weeks after starting treatment & dose titration.
• Maintain at the target dose (or highest tolerated dose) indefinitely unless adverse effects occur.
• Once treatment is stable, measure renal function and serum electrolytes at least every 6
months.
• Sick day rules :
– Advise the person that if they develop diarrhoea and vomiting while taking they should maintain their fluid intake and stop for 1-2 days until they recover.
– If symptoms persist beyond 2 days they should see a GP and have their renal function checked.

62
Q

Beta Blockers for HF patients:

A

• Acutely can decrease myocardial contractility & worsen heart failure.
• Long term improve survival of stable patients with heart failure by blocking the damaging effects of
overactive sympathetic activity
• Avoid adverse effects by starting low dose
• Carvedilol, bisoprolol & metoprolol given with an ACE inhibitor & diuretic for about 1 year have been
found in trials to decrease mortality from 11-17% to 7-12%
• Most patients with heart failure with reduced ejection fraction should be offered treatment with a beta
blocker
• the beta-blockers licensed in the UK for the treatment of heart failure are bisoprolol, carvedilol, and nebivolol.

63
Q

Isosorbide Dinitrate & Hydralazine

A

• In some situations HF patients are unable to tolerate either or both ACEI or ACEII
• Can be used as alternative vasodilator in these patients.
• This combination improves exercise tolerance in heart failure patients but produces only modest reduction in mortality.
• Evidence available suggests this combination is of particular benefit to Afrocarribean patients although its benefit to Caucasians is yet to be fully established.

64
Q

Ivabradine:

A

• In the UK, ivabradine is now recommended for patients with symptomatic heart failure with reduced ejection fraction (class II to IV) who :
– Are in sinus rhythm with a resting heart rate of 75 beats per minute or more, and
– Are symptomatic in spite of standard treatment including a beta blocker, an ACE inhibitor and an
aldosterone antagonist OR who are genuinely intolerant of beta blockers, and – Have a left ventricular ejection fraction of 35% or less
• Carefully monitor patients taking ivabradine for bradycardia or its symptoms (for example dizziness, fatigue and hypotension)

65
Q

Digoxin (HF)

A

• Beneficial in patients with current or prior symptoms of heart failure or reduced LVEF, especially those with atrial fibrillation.
• When added to ACE inhibitors, beta-blockers, and diuretics, digoxin can reduce symptoms, prevent hospitalisation, control rhythm, and enhance exercise
• Digoxin should be used cautiously with plasma level monitoring. • Digoxin toxicity ( digifab anti toxin)
Check bloods 6 hour post dose

66
Q

ENTRESTO – Sacubitril / valsartan (HF)

A

Stops breakdown of BNP
• Sacubitril valsartan is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction, only in people:
– with New York Heart Association (NYHA) class II to IV symptoms and
– with a left ventricular ejection fraction of 35% or less and
– who are already taking a stable dose of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor-blockers (ARBs).
• Concomitant administration of an angiotensin-II receptor antagonist plus neprilysin with an ACE inhibitor, or within 36 hours of the last dose of an ACE inhibitor, is not recommended.
• Treatment with sacubitril/valsartan reduces cardiovascular death by reducing both worsening heart failure and sudden cardiac death
• The most commonly reported adverse reactions during treatment with sacubitril valsartan were hypotension, hyperkalaemia and renal impairment

67
Q

Dapagliflozin & Empagliflozin (HF)

A

• Dapagliflozin & Empagliflozin are recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction in adults, only if it is used as an add-on to optimised standard care with:
• ACE inhibitors or ARBs, with beta blockers, and, if tolerated, MRAs, or • sacubitril valsartan, with beta blockers, and, if tolerated, MRAs.
• Start treatment of symptomatic heart failure with reduced ejection fraction with on the advice of a heart failure specialist.
• Monitor for adverse events

68
Q

NICE treatment for chronic heart failure:

A

• To relieve symptoms of fluid overload:
o Prescribe a diuretic (e.g. furosemide).
o Titrate the dose up or down according to symptoms.
o Review the dose and adjust as necessary after introducing other drug treatments for heart failure.

• To reduce morbidity and mortality prescribe:
o An angiotensin-converting enzyme (ACE) inhibitor and a beta-blocker.
o An angiotensin-II receptor antagonist (AIIRA) may be considered if the person develops intolerable side effects to the ACE inhibitor.

• Introduce one drug at a time.
• Add the second drug once the person is stable on the first drug.

69
Q

What patient advice should you give to someone with heart failure?

A

Reduce salt consumption
Fluid restriction 1.5 - 2litres
Stop smoking/ alcohol
Increase PA
Improve nutritional status
Recommend immunisations

70
Q

Complications of heart failure:

A

Complications of heart failure
• Cardiac arrhythmias

• Depression
– Major depressive disorder is present in up to 20% of people with heart failure

• Cachexia (wasting)
– This is defined as the loss of 6% or more of total body weight within the previous 6-12 months. Wasting occurs in lean tissue (muscle mass), and fat

• Chronic kidney disease (CKD)
– CKD is common in people with heart failure and is strongly associated with increased morbidity and
mortality

• Sexual dysfunction
– Sexual dysfunction is common in people with heart failure. This may be related to cardiovascular
disease, fatigue, weakness, the use of drugs (such as beta-blockers), or depression and anxiety

• Sudden cardiac death
– About half of the deaths in people with heart failure are related to sudden cardiac death

71
Q

Acute Heart Failure:

A

• Develops rapidly and can be immediately life-threatening due to a lack of time to undergo any compensatory changes.
• Due to acute infection (sepsis), acute myocardial infarction, heart valve dysfunction, severe arrhythmias or operations (cardiopulmonary bypass).
• managed by pharmacological, mechanical and surgical interventions despite its aetiology

Symptoms:
Coughing up pink foamy mucus
Lack of appetite/ nausea
Sudden swelling of the abdomen, legs, ankles and feet
Severe shortness of breath
Rapid, irregular heart beat
Fatigue and weakness
Sudden weight gain from fluid retention

72
Q

Symptoms of atrial fibrillation

A

Breathlessness
Palpitations
Syncope or dizziness
Chest discomfort
Stroke or transient ischaemic attack

73
Q

Detection and diagnosis of AF:

A

Perform a manual pulse palpate on to assess for presence of an regular pulse
Perform 12 lead ECG to diagnose AF
If suspected paroxysmal AF do ambulatory ECG

74
Q

CHADSVAS vs HASBLED

A

To assess the risk of using an anti coagulation against the risk of bleeding out

75
Q

What is the treatment pathway for a patient with AF?

A

Haemodynamically unstable - direct current cardioversion

HD Stable
1) Rate control
2) Anti-coagulate (check CHADSVAS)
3) consider cardioversion:

If AF <48 hours + low risk of stroke = cardiovert + anticoagulants for 4 weeks
If AF >48 hours + risk of stroke either TEE echocardiogram to check for a current clot in atrium if not present cardiovert + oral AC for 4 weeks
or if thrombus present oral AC for 3 weeks, re check then potentially cardiovert

76
Q

Rate Control Drugs for AF:

A

Block the AV node to decrease HR

Beta Blockers
- Bisoprolol, Atenolol
Contra Indication - COPD as block B2 receptors

Calcium Channel Blockers
- Veraprimil, diltiazem
Contra Indication- Heart Failure

Digoxin - take a while to kick in
Good for hypertension / HF

Amioderone (Rhythm + Rate)

77
Q

Rhythm control drugs for AF:

A

Drug = pharmacological cardioversion
Type 1a
Type 1c
Type 3
CI- Increase risk of tossades de point

Flecanide, BB- sotalol, Amiodarone

	○ Long term rhythm control drugs:
		▪ Beta blockers – 1st line 
		▪ Dronedarone – 2nd line, maintain normal rhythm when they’ve had successful cardioversion
		▪ Amiodarone – in patients with heart failure or left ventricular dysfunction
78
Q

what does CHA2DS2VAS stand for?

A

CHF +1
HTN +1
Age >75 +2
Diabetes +1
Stroke/ TIA +2
Vascular Disease +1
Age 65-74 +1
Sex- Female +1
2 or more = AC NEEDED

79
Q

Types of anticoagulants for AFib:

A

Warfarin
DOACs
Heparin

80
Q

Treatment for narrow regular and irregular tachyarrhythmias:
AVRT/AVNRT
AFlutter
Fat

A

Vagal Monouver - Increases vagal tone, Decrease AV node
Adenosine (6mg) - Blocks AV Node
AFlut or FAT BB/CCB
Cardiovert - priority if haemodynamically unstable

Long Term:
Catheter Ablation

81
Q

Treatment for wide regular tachyarrhythmia:
VTach vs SVT BBB

A

TREAT FOR VTACH
Put pads on first
Amiodarone or Procainimide
Cardioversion

82
Q

Treatment for SVT BBB- only if you are 100% it is this and not V Tach

A

Adenosine

Cardioversion
Look for underlying cause
If MI- PCI? Auto implantable cardiac debrillators?

83
Q

Treatment for tossades de point (polymorphic VTach)

A

Amiodarone
Cardiovert
D Fib on stand by

Once stable give Mg Sulphate, K+, discontinue offending meds, isoprotenolol to increase HR

DONT GIVE ABCD (adenosine, beta blocker, CCB, Digoxen)

84
Q

Treatment of heart block (bradyarrhythmias):

A

Discontinuation of AV nodal blocking drugs

Atropine to decrease PNS and increase HR
Epi
PACE

Once patient is stable treat underlying cause:

Inferior wall MI
Hypercalaemia
Overdose on CCB/BB/Digoxen
Limes disease

85
Q

Advantages and disadvantages of anticoagulation:

A

Benefits
Can save life & limb from thrombo-embolism
For people with AF – overall 60% reduction of stroke
-about 80-90 strokes will be prevented each year for every 1000
-about 25 strokes will be prevented each year for every 1000

Problems
Anticoagulants are one of the classes of medicines most frequently identified as causing preventable harm & admissions to hospital (NPSA 2007)
Major cause of bleeding which can be fatal (NPSA 2007)
Major cause of litigation (use or non-use) stroke vs bleeding risk
Dose adjustments frequently required to avoid over or under anticoagulation

86
Q

What are some things we use anticoagulants for?

A

AF
Deep Vein Thrombosis
Pulmonary Embolism

87
Q

Mode of Action of Warfarin

A

Inhibits vitamin K clotting factors.
Use with heparin as doesn’t work instantly

Prevents the vitamin K promoted carboxylation of glutamic acid residues of factors II, VII, IX and X.
50% drop in factor VII levels in 24 hours
50% drop in factor II levels in 4 days
Full anticoagulation in 48-72 hours
Rapid fall in protein C and S levels-in first 2-3days can increase risk of thrombosis.

88
Q

What is INR?

A

International normalised range

As 1 size doesn’t fit all
To see the dose of warfarin which should be used in AC medication

89
Q

Contra Indication to warfarin

A

Bleeding risk
Haemorrhagic stroke
Pregnancy
Re occurrent falls
Uncontrolled hypertension
Medication - eg ibroprofen, aspirin as increase risk of GI bleed

90
Q

What tests should be performed prior to commencing with warfarin?

A

Prothrombin time (PT)
Activated partial thromboplastin time (APTT) u Platelet count
Full Blood Count
Liver Function Test
Baseline INR
(if INR >1.4 review management plan) check why its higher than 0

91
Q

What strengths of warfarin are availed and what colours are they?

A

1mg brown
3mg blue
5mg pink
0.5mg white

92
Q

If a patient is allergic or resistant to warfarin, what alternatives are there?

A

Acenocoumarol
Phenindione
DOACs - rivaroxaban
Heparins

93
Q

Unfractioned heparin:

A

AnticoagulantHigh molecular weight molecule- highly ionised

Therefore – not absorbed via the GI tract
So – it must be given by IV infusion or by subcutaneous injection.
When do you use? : High risk patients / renal impairment
Monitoring & dose adjustment needed – check your trust protocol!
Protamine used to reverse action

94
Q

What should you monitor if a patient is on unfractionated heparin?

A

Prothrombin time (PT) - heparin
Activated partial thromboplastin time (APTT) - heparin
Platelet count - HIT (heparin infused thrombolysis <100 don’t use AC)
Full blood count
Liver function test
Potassium

95
Q

What are ad name some low molecular weight heparins?

A

Enoxaparin, dalteparin, tinzaparin sodium, bemiparin

Longer half life - once or twice a day dosing
Dosage based on body weight
Advantages: fixed dose , no lab, highly predictable plasma levels
Disadvantages: more expensive

96
Q

What can you use a LMWH for? Give some examples

A

PE
DVT
Thromboprophylaxis
Acute coronary syndrome

Examples
Fondaparinux
Enoxaparin
Daltaparin
Tinzaparin
DOSE ADJUSTMENTS – Renal , Body weight, Increased risk

97
Q

Contrainications of Enoxaparin.

A

Risk of bleeding, Low platelet
BNF:
Acute bacterial endocarditis; after major trauma; avoid injections containing benzyl alcohol in neonates; epidural anaesthesia with treatment doses; haemophilia or other haemorrhagic disorders; peptic ulcer; recent cerebral haemorrhage; recent surgery to eye; recent surgery to nervous system; spinal anaesthesia with treatment doses; thrombocytopenia (including history of heparin-induced thrombocytopenia)

98
Q

Name some direct oral anticoagulants (DOACS)

A

Dabigatran Rivaroxaban Apixaban Edoxaban

99
Q

DOAC Indications:

A

Licensed for:

Non-valvular AF (NB differences in criteria)
DVT / PE Treatment & prophylaxis of recurrent VTE
Thromboprophylaxis of DVT or PE after an acute DVT/PE
Thromboprophylaxis after hip or knee replacement (except edoxaban)
Rivaroxaban : Prophylaxis of atherothrombotic events following an acute coronary syndrome with elevated cardiac biomarkers (in combination with aspirin alone or aspirin and clopidogrel)
Check NICE guidance as indications can change regularly.

100
Q

Benefits of DOACS?

A

Small half life - good if they need taking off them
No need for INR monitoring
Predictable Anticoagulant response
Rapid onset (1-4 hours)
Lower risk of bleed overall with much reduced intracranial bleed (0.3% vs. 0.76%)
Give stroke protection equivalent to Warfarin (only Dabigatran 150mg gives added benefit)
Rivaroxaban , Apixaban & Edoxaban : can go in compliance aids / can be crushed

101
Q

Who would use DOAC’S?

A

Patients who cannot tolerate Warfarin due to:
Significant side effects e.g. Alopecia
Poor INR control despite being compliant (Time in therapeutic range should be less than 65%- Rosendaal score- Cardiac Network )
INR> 5 while compliant with no known cause more than twice in a year
Now first line treatment in majority of patients with PE / DVT/ non valvular AF

102
Q

Contraindications of DOAC’S

A

• a lesion or condition, if considered a significant risk factor for major bleeding.
This may include:
• current or recent gastrointestinal ulceration
• presence of malignant neoplasm at high risk of bleeding
• recent brain or spinal injury
• recent brain, spinal, or ophthalmic surgery
• recent intracranial haemorrhage
• known or suspected oesophageal varices
• arteriovenous malformation
• vascular aneurysms, or major intraspinal or intracerebral vascular abnormalities

• concomitant treatment with any other anticoagulant agent—eg:
• unfractionated heparin
• low molecular weight heparin (such as enoxaparin or dalteparin)
• heparin derivatives (such as fondaparinux)
• oral anticoagulants (such as warfarin).

103
Q

DOAC specific cautions / dosage

A

Check;
Interactions
Indications ( may differ )
Age (Apixaban & Dabigatran dosage advice)
Weight (Apixaban & Edoxaban )
Renal function - - impaired renal function may constitute a contraindication or recommendation not to use the anticoagulant medicine, or may require a dose reduction
- -other conditions, procedures, and concomitant treatments (eg, non-steroidal anti- inflammatory drugs, antiplatelets), which may increase the risk of major bleeding

Rivaroxaban : WITH FOOD
80% biovailability with food u 66% without food

104
Q

How do you reverse DOAC’S?

A

Specific reversal agents are available for dabigatran (Praxbind▼, idarucizumab)

Apixaban and Rivaroxaban (Ondexxya▼, andexanet alfa)

Currently no specific authorised reversal agent available for Edoxaban.

Cardiovascular (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions